Update in the Treatment of High-grade Gliomas
作者： Rimas V. Lukas , Martin Kelly Nicholas
DOI: 10.1016/J.NCL.2013.03.005
关键词: Combined modality 、 Chemotherapy 、 Primary Brain Tumors 、 Radiation therapy 、 Radiology 、 Molecular classification 、 Medicine
摘要: Advances in the molecular classification of high-grade gliomas are laying groundwork for potential changes treatment gliomas. Currently, a combined modality approach involving surgery, radiation therapy, and chemotherapy is most often used The authors review recent advances these primary brain tumors.
elsevier.com
sci-hub.se 参考文章(94)
Paul A. Clark, Mari Iida, Daniel M. Treisman, Haviryaji Kalluri, Sathyapriya Ezhilan, Michael Zorniak, Deric L. Wheeler, John S. Kuo, Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR-Targeted Inhibition Neoplasia. ,vol. 14, pp. 420- IN13 ,(2012) , 10.1596/NEO.12432
Karima Mokhtari, François Ducray, Johan M Kros, Thierry Gorlia, Ahmed Idbaih, Martin Taphoorn, Pieter Wesseling, Khe Hoang‐Xuan, Martin Van den Bent, Marc Sanson, None, Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951. Cancer. ,vol. 117, pp. 3014- 3026 ,(2011) , 10.1002/CNCR.25827
Craig Horbinski, C Ryan Miller, Arie Perry, Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade Brain Pathology. ,vol. 21, pp. 57- 73 ,(2011) , 10.1111/J.1750-3639.2010.00453.X
Ashwatha Narayana, Deborah Gruber, Saroj Kunnakkat, John G. Golfinos, Erik Parker, Shahzad Raza, David Zagzag, Patricia Eagan, Michael L. Gruber, A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. Journal of Neurosurgery. ,vol. 116, pp. 341- 345 ,(2012) , 10.3171/2011.9.JNS11656
Colleen Murphy, Tom Pickles, Margaret Knowling, Brian Thiessen, Concurrent modified PCV chemotherapy and radiotherapy in newly diagnosed grade IV astrocytoma. Journal of Neuro-oncology. ,vol. 57, pp. 215- 220 ,(2002) , 10.1023/A:1015797713149
David M Siebert, Sophia F Shakur, Peter Pytel, Lukas Rimas, EGFR as a therapeutic target in glioblastoma Reviews in Health Care. ,vol. 3, pp. 33- 49 ,(2011) , 10.7175/RHC.V3I1.75
G Cairncross, D Macdonald, S Ludwin, D Lee, T Cascino, J Buckner, D Fulton, E Dropcho, D Stewart, C Schold, Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. ,vol. 12, pp. 2013- 2021 ,(1994) , 10.1200/JCO.1994.12.10.2013
M J Ratain, M E Dolan, L R Wilson, D Bertucci, R L Schilsky, N J Vogelzang, R B Ewesuedo, S Mani, Phase I Clinical and Pharmacological Study of O6-Benzylguanine Followed by Carmustine in Patients with Advanced Cancer Clinical Cancer Research. ,vol. 6, pp. 3025- 3031 ,(2000)
Nader Sanai, Mitchel S. Berger, Recent surgical management of gliomas. Advances in Experimental Medicine and Biology. ,vol. 746, pp. 12- 25 ,(2012) , 10.1007/978-1-4614-3146-6_2
H S Friedman, D M Kokkinakis, J Pluda, A H Friedman, I Cokgor, M M Haglund, D M Ashley, J Rich, M E Dolan, A E Pegg, R C Moschel, R E McLendon, T Kerby, J E Herndon, D D Bigner, S C Schold, Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma Journal of Clinical Oncology. ,vol. 16, pp. 3570- 3575 ,(1998) , 10.1200/JCO.1998.16.11.3570